Takeda Vietnam’s Impactful Journey in Dengue Prevention
Takeda’s representative received the award at Healthcare Asia Pharma Awards 2026.
As Dengue fever continues to pose a major public health challenge in Vietnam, the need for proactive prevention is increasingly emphasized to reduce the disease burden. In this context, health communication plays a critical role in helping the public gain accurate understanding and adopt appropriate preventive practices.
In alignment with the healthcare sector, Takeda Vietnam has implemented a range of innovative communication initiatives on Dengue, using diverse approaches to enhance public awareness of the disease and its risks.
From a communication campaign to international recognition
One of Takeda Vietnam’s standout initiatives is the DeRIGHT-V campaign, designed to ‘demystify’ common misconceptions about Dengue through creative content and communication formats.
The campaign’s effectiveness has been recognized through international and domestic awards. In 2026, it received the “Marketing & Communications Initiative of the Year” award at the Healthcare Asia Pharma Awards - a prestigious annual healthcare award organized by Healthcare Asia to honor companies with innovative initiatives and meaningful contributions to healthcare systems across Asia. Previously, the campaign also won “TVC of the Year” at the Van Xuan Awards 2025.
The name “DeRIGHT-V” reflects Takeda’s goals in its efforts to support Vietnam in responding to Dengue: ‘De’ represents the first two letters of Dengue and also ‘Demystify’ - addressing persistent misconceptions about the disease; “RIGHT” represents the goal of bringing correct and more science-based awareness in disease prevention. “V” (Victory) stands for Vietnam and the aspiration for a victory over the disease.
Within its first two years (2024–2025), the campaign worked to dispel common misconceptions through a series of short videos, turned the familiar buzz of mosquitoes into the trending “Mosquito Beat Drop,” and introduced an interactive storytelling station on dengue complications at the Saigon Zoo and Botanical Gardens in Ho Chi Minh City. These initiatives have been continuously refreshed, helping to foster more proactive health behaviors within the community.
As a result, the campaign achieved over 733 million impressions and 78 million views, alongside an 11-fold increase in search volume related to Dengue and Dengue vaccination compared to the previous two years.
To expand its impact, Takeda collaborates with local Centers for Disease Control and media agencies to provide official epidemiological information, helping communities accurately understand the severity of Dengue.
Mr. Benjamin Ping, General Manager of Takeda Vietnam, shared: “Although Dengue awareness is high, our research suggests that the public may not fully understand the risk and severity associated with Dengue.”
“Vietnam records over 100,000 Dengue cases every year. Dengue occurs year-round, across the country from south to north, and affects all age groups - children, adults and the elderly. Dengue can result in hospitalization, often requiring parents to take time off work while children miss extended periods of school. Therefore, clear and effective health communication is essential to help people understand the disease and proactively adopt preventive measures to protect themselves and their families, thereby reducing its broader socio-economic impact.” - Mr. Benjamin Ping said.
Strengthening scientific foundations of Dengue fever prevention
Over the past 2 years, Takeda Vietnam has collaborated with medical associations, central hospitals, and training institutions to conduct more than 1,000 educational and knowledge-updating activities, reaching over 7,000 healthcare professionals nationwide. A highlight was the Vietnam Dengue Summit 2025, which brought together more than 700 local and international experts.
Based on scientific foundation, Takeda Vietnam also advances research and development of preventive solutions. Notably, Takeda’s Dengue vaccine has been recommended by the World Health Organization (WHO) for use in countries with a high disease burden and is currently approved in more than 40 countries, with over 21 million doses distributed globally.
These efforts reflect Takeda Vietnam’s comprehensive approach to Dengue prevention, contributing to a more proactive community in addressing health risks.
*This content is provided by Takeda Vietnam. This information is available to the general public for informational purposes only. It is not intended to substitute for consultation with a relevant expert or health care provider.
C-ANPROM/VN/NON/0143 Apr 2026